跳至主要内容
临床试验/NCT00621374
NCT00621374已完成不适用

Pilot Study of CBT and Self-hypnosis Training for Pain in Persons With Multiple Sclerosis

University of Washington2 个研究点 分布在 1 个国家目标入组 22 人开始时间: 2008年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
22
试验地点
2
主要终点
A composite of average daily pain intensity measured using a 0-10 NRS via four phone interviews performed on different days by research staff.

研究概览

简要总结

The purpose of this study is to see if treatments that include components of self-hypnosis training and cognitive behavioral therapy (CBT) can help decrease pain in people with MS.

详细描述

This study examined the benefits of two treatments, individually and together, for helping individuals with MS manage their pain. We conducted a time series design in which MS subjects received all four treatment conditions in two orders (randomly assigned): (1) Control (education intervention-CONT),Self-Hypnosis Training (HYP), Cognitive Behavioral Therapy (CBT), HYP-CBT(a combination of HYP and CBT) and (2) CONT, CBT, HYP, HYP-CBT. Subjects attended 16 60-minute treatment sessions conducted by one of the study's psychologists either at the UW,HMC or in the subject's home. Each subject received four treatment sessions of each treatment module listed above. Primary outcome measures were collected via the telephone and mail by research personnel blind to the treatment condition before treatment, immediately after treatment ends and one month after treatment ends. Secondary outcome measures were collected at the same assessment points via pencil and paper interviews completed by subjects.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Chronic ongoing pain (i.e., pain at all times) with an average pain intensity of at least 4/10 on 0-10 numeric rating scale
  • Pain is either worse or started since the onset of other MS symptoms.
  • Pain of at least six months duration.
  • Reads, speaks and understands English.
  • Definitive diagnosis of multiple sclerosis (MS)
  • At least 18 years of age
  • Recruited from a recruitment source approved by the IRB

排除标准

  • Severe cognitive impairment resulting in the inability to verbally comprehend, learn, and recall new auditory verbal information, as reflected by a TICS score of 20 or less.
  • Currently participating in counseling and/or psychotherapy more than once a week.
  • Currently taking anti-psychotic medications
  • Has been hospitalized for psychiatric reasons in the past six months
  • Experiencing current active suicidal ideation.
  • Has received treatment or participated in a clinical trial that involved significant elements of either CBT or hypnosis within the past year.

结局指标

主要结局

A composite of average daily pain intensity measured using a 0-10 NRS via four phone interviews performed on different days by research staff.

时间窗: Before treatment, after each treatment module, and 1-month after the final treatment module.

次要结局

  • Sleep quality- Medical Outcomes Sleep Study Measure (Hays et al., 2005)(before treatment, after each treatment module, one month after 4th treatment modules)
  • Depression- (CMDI; Nyenhuis et al., 1998)(before treatment, after each treatment module, one month after 4th treatment modules)
  • Catastrophizing cognitions- (PCS; Sullivan et al. 1995)(before treatment, after each treatment module, one month after 4th treatment modules)
  • Adaptive cognitions (CPAQ; McCracken et al., 2004)(before treatment, after each treatment module, one month after 4th treatment modules)
  • Distinguishing neuropathic vs. non-neuropathic pain (S-LANSS; Bennett et al., 2005)(before treatment, after each treatment module, one month after 4th treatment modules)
  • Pain Interference-(Brief Pain Inventory, Cleeland et al., 1994)(before treatment, after each treatment module, one month after 4th treatment modules)
  • Impact of Fatigue (FIS; Fisk et al. 1993)(before treatment, after each treatment module, one month after 4th treatment modules)
  • Fatigue Severity (FSS; Krupp et al., 1989)(before treatment, after each treatment module, one month after 4th treatment modules)
  • Health Status (SF-36; Ware et al., 1992)(before treatment, after each treatment module, one month after 4th treatment modules)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mark Jensen

Principal Investigator

University of Washington

研究点 (2)

Loading locations...

相似试验